Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 5
2018 16
2019 4
2020 11
2021 9
2022 9
2023 15
2024 27
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study.
Sood S, Rimke A, Rankin BD, Abduelmula A, Georgakopoulos JR, Maliyar K, Bagit A, Leung F, Stark LA, Devani AR, Vender R, Yeung J, Prajapati VH. Sood S, et al. Among authors: georgakopoulos jr. J Am Acad Dermatol. 2024 Nov;91(5):936-939. doi: 10.1016/j.jaad.2024.05.085. Epub 2024 Jun 15. J Am Acad Dermatol. 2024. PMID: 38885841 No abstract available.
Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review.
Sood S, Varenbut J, Bagit A, Perlmutter J, Maliyar K, Sachdeva M, Abduelmula A, Georgakopoulos JR, Mufti A, Prajapati VH, Yeung J. Sood S, et al. Among authors: georgakopoulos jr. J Am Acad Dermatol. 2025 Jan;92(1):135-137. doi: 10.1016/j.jaad.2024.08.066. Epub 2024 Sep 16. J Am Acad Dermatol. 2025. PMID: 39293573 Free article. No abstract available.
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review.
Sood S, Rimke A, Rankin BD, Abduelmula A, Georgakopoulos JR, Maliyar K, Bagit A, Leung F, Devani AR, Vender R, Yeung J, Prajapati VH. Sood S, et al. Among authors: georgakopoulos jr. J Am Acad Dermatol. 2024 Dec;91(6):1265-1267. doi: 10.1016/j.jaad.2024.07.1515. Epub 2024 Aug 23. J Am Acad Dermatol. 2024. PMID: 39182686 Free article. No abstract available.
Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Long-Term (Week 52) Data from a Real-World Multicenter Retrospective Review.
Rankin BD, Sood S, Park YJ, Rimke A, Abduelmula A, Georgakopoulos JR, Maliyar K, Leung F, Stark LA, Devani AR, Yeung J, Prajapati VH. Rankin BD, et al. Among authors: georgakopoulos jr. Dermatitis. 2024 Oct 24. doi: 10.1089/derm.2024.0208. Online ahead of print. Dermatitis. 2024. PMID: 39446652 No abstract available.
84 results